Cargando…
Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis
Background: Pulmonary fibrosis (PF) is a progressive lung disease characterized by fibroblast accumulation and collagen deposition, resulting in lung scarring and impaired gas exchange. Current treatments for idiopathic pulmonary fibrosis (IPF) have limited efficacy and significant side effects. Hea...
Autores principales: | Yoo, Young Jo, Jeon, Seulgi, Jin, Hee, Won, Hee Yeon, Jeong, Mi Gyeong, Cho, Yeseul, Hwang, Eun Sook, Na, Younghwa, Cho, Jaeho, Lee, Yun-Sil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352808/ https://www.ncbi.nlm.nih.gov/pubmed/37469871 http://dx.doi.org/10.3389/fphar.2023.1203033 |
Ejemplares similares
-
The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis
por: Jeon, Seulgi, et al.
Publicado: (2023) -
HSP27 inhibitor attenuates radiation-induced pulmonary inflammation
por: Kim, Jee-Youn, et al.
Publicado: (2018) -
Radiation-Induced Lung Fibrosis: Preclinical Animal Models and Therapeutic Strategies
por: Jin, Hee, et al.
Publicado: (2020) -
Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules
por: Kim, Jee Hye, et al.
Publicado: (2016) -
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
por: Hwang, Soo-Yeon, et al.
Publicado: (2020)